Envista (NYSE:NVST) Announces Earnings Results, Misses Expectations By $0.05 EPS

Envista (NYSE:NVST) released its earnings results on Wednesday. The company reported $0.26 EPS for the quarter, missing the consensus estimate of $0.31 by ($0.05), Briefing.com reports. The firm had revenue of $623.60 million during the quarter, compared to the consensus estimate of $634.85 million. Envista had a negative net margin of 3.90% and a positive return on equity of 6.31%. The company’s revenue was down .6% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.38 EPS.

Envista Stock Performance

Shares of NVST traded up $0.06 during mid-day trading on Thursday, reaching $19.81. The company’s stock had a trading volume of 4,654,068 shares, compared to its average volume of 2,317,987. The company has a current ratio of 2.23, a quick ratio of 1.90 and a debt-to-equity ratio of 0.33. The stock has a market cap of $3.40 billion, a P/E ratio of -32.66, a PEG ratio of 3.72 and a beta of 1.35. Envista has a 1-year low of $18.09 and a 1-year high of $38.42. The business has a 50-day simple moving average of $20.80 and a two-hundred day simple moving average of $22.59.

Wall Street Analyst Weigh In

A number of analysts have recently commented on NVST shares. Leerink Partnrs reissued an “underperform” rating on shares of Envista in a research report on Monday, February 26th. SVB Leerink assumed coverage on shares of Envista in a research report on Monday, February 26th. They set an “underperform” rating and a $19.00 price target on the stock. Jefferies Financial Group downgraded shares of Envista from a “buy” rating to a “hold” rating and reduced their price objective for the stock from $30.00 to $23.00 in a research note on Friday, February 9th. William Blair downgraded Envista from an “outperform” rating to a “market perform” rating in a research report on Thursday, February 8th. Finally, UBS Group assumed coverage on Envista in a report on Friday, January 5th. They set a “neutral” rating and a $26.00 target price on the stock. Three analysts have rated the stock with a sell rating, seven have assigned a hold rating and two have given a buy rating to the company. Based on data from MarketBeat, the stock presently has an average rating of “Hold” and an average price target of $26.27.

Envista Company Profile

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.